Search results
Showing results for
Oxford researchers part of major UK initiative to understand chronic pain
10 May 2022
Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.
Professor Irene Tracey nominated as Vice-Chancellor of the University of Oxford
10 May 2022
Professor of Anaesthetic Neuroscience Irene Tracey, former head of the Nuffield Department of Clinical Neurosciences, has been nominated as the next Vice-Chancellor of the University of Oxford.
MRC BNDU receives a Wellcome Collaborative Award for Parkinson’s research
29 April 2022
We are delighted to announce that the MRC Brain Network Dynamics Unit has received Collaborative Award funding from Wellcome for a substantial multi-year research programme designed to advance the understanding of why dopamine-producing nerve cells are especially vulnerable in Parkinson’s.
Unique study of vascular disease reaches 20th anniversary
19 April 2022
The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.
Little understood brain region linked to how we perceive pain
28 March 2022
A new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.
New Public Engagement Ambassadors
10 March 2022
We're delighted to introduce our new cohort of public engagement ambassadors for 2022.
New funding awarded to study persistent pain in inflammatory arthritis
7 March 2022
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
Brain regions related to smell show decline following mild COVID-19
7 March 2022
Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.
Sir Roger Bannister Prize Winners 2020/21
7 March 2022
Congratulations to Alexander Hayes and Lily Watson for their success in this year's competition.
First-in-human implant of a “closed-loop” bioelectronic research system for investigating treatments for brain disorders
7 February 2022
Researchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in Parkinson’s-like Multiple Systems Atrophy (MSA).
Attention and memory deficits persist for months after recovery from mild COVID
19 January 2022
Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.
New Academic Visitor from Nigeria
19 January 2022
Associate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.
New spinout company: Human-Centric Drug Discovery
7 January 2022
Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
Funding received for research into Motor Neuron Disease
5 January 2022
A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
New Year's Honours for Professor Irene Tracey
4 January 2022
Professor Irene Tracey FMedSci, MAE, Professor of Anaesthetic Neuroscience and Warden of Merton College, has been appointed CBE for services to medical research.
Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia
17 December 2021
A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.
Protein test could lead to earlier and better diagnosis of Parkinson’s
13 December 2021
Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.
Nine new Professors
8 December 2021
Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.